The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ia/Ib study evaluating the safety and efficacy of intratumorally administrated OH2, an oncolytic herpes simplex virus 2, in unresected stage IIIC to IV melanoma patients.
 
Xuan Wang
Consulting or Advisory Role - Oriengene
 
Chuanliang Cui
No Relationships to Disclose
 
BIN LIAN
No Relationships to Disclose
 
Lu Si
No Relationships to Disclose
 
Zhihong Chi
No Relationships to Disclose
 
Xinan Sheng
Speakers' Bureau - BeiGene; Junshi Pharmaceuticals; Novartis; Pfizer; RemeGen
 
Yan Kong
No Relationships to Disclose
 
Han Hu
Consulting or Advisory Role - Binhui Biopharmaceuticals, Ltd.
 
Xiangyong Gu
Employment - Binhui Biopharmaceuticals, Ltd.
Leadership - Binhui Biopharmaceuticals, Ltd.
 
Caili Li
No Relationships to Disclose
 
Lili Mao
Honoraria - MSD; Novartis; Shanghai Junshi BioSciences
Research Funding - MSD
 
Xue Bai
Other Relationship - Bristol-Myers Squibb
 
Bixia Tang
No Relationships to Disclose
 
Xieqiao Yan
No Relationships to Disclose
 
Siming Li
No Relationships to Disclose
 
Li Zhou
No Relationships to Disclose
 
Binlei Liu
Employment - Binhui Biopharmaceuticals, Ltd.
Leadership - Binhui Biopharmaceuticals, Ltd.
Stock and Other Ownership Interests - Binhui Biopharmaceuticals, Ltd.
Patents, Royalties, Other Intellectual Property - Binhui Biopharmaceuticals, Ltd.
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere